Show simple item record

dc.contributor.authorStuve, O
dc.contributor.authorSoerensen, PS
dc.contributor.authorLeist, T
dc.contributor.authorGiovannoni, G
dc.contributor.authorHyvert, Y
dc.contributor.authorDamian, D
dc.contributor.authorDangond, F
dc.contributor.authorBoschert, U
dc.date.accessioned2021-01-12T15:13:55Z
dc.date.available2019-05-07
dc.date.available2021-01-12T15:13:55Z
dc.date.issued2019-06
dc.identifier.issn1756-2856
dc.identifier.otherARTN 1756286419854986
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/69637
dc.relation.ispartofTHERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subjectcladribine tabletsen_US
dc.subjectCLARITYen_US
dc.subjectCLARITY Extensionen_US
dc.subjectlymphocytesen_US
dc.subjectmultiple sclerosisen_US
dc.subjectORACLE-MSen_US
dc.subjectsubsetsen_US
dc.titleEffects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markersen_US
dc.typeArticleen_US
dc.identifier.doi10.1177/1756286419854986
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478587000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume12en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States